STANLEY SCHEIDLER: Open Payments
NPI 1548243900 · HAMILTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,481 in 204 payments from 35 companies in 2025. Trend: 2023 $3,258 · 2024 $3,367 · 2025 $3,481
Food & beverage: $3,481
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $529 |
| AstraZeneca Pharmaceuticals LP | 17 | $492 |
| Bayer Healthcare Pharmaceuticals Inc. | 17 | $318 |
| Vanda Pharmaceuticals Inc. | 11 | $264 |
| Otsuka America Pharmaceutical, Inc. | 21 | $245 |
| GlaxoSmithKline, LLC. | 14 | $197 |
| Merck Sharp & Dohme LLC | 6 | $145 |
| Novo Nordisk Inc | 13 | $142 |
| Dexcom, Inc. | 5 | $136 |
| Alkermes, Inc. | 4 | $107 |
Products named: AIRSUPRA, Kerendia, REXULTI, VRAYLAR, TRELEGY ELLIPTA, QULIPTA, HETLIOZ, VERQUVO.
Industry payments across OH — which companies pay providers there.
